Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 97, Issue 9, Pages 3637-3665Publisher
ELSEVIER SCIENCE INC
DOI: 10.1002/jps.21281
Keywords
magnetic resonance spectroscopy; magnetic resonance imaging; preclinical research; pharmaceutical sciences; metabonomics; lung imaging; skin diseases
Ask authors/readers for more resources
This review presents an overview of some recent magnetic resonance (MR) techniques for pharmaceutical research. MR is noninvasive, and does not expose subjects to ionizing radiation. Some methods that have been used in pharmaceutical research MR include magnetic resonance spectroscopy (MRS) and magnetic resonance imaging (MRI) methods, among them, diffusion-weighted MRI, perfusion-weighted MRI, functional MRI, molecular imaging and contrast-enhance MRI. Some applications of MR in pharmaceutical research include MR in metabonomics, in vivo MRS, studies in cerebral ischemia and infarction, degenerative joint diseases, oncology, cardiovascular disorders, respiratory diseases and skin diseases. Some of these techniques, such as cardiac and joint imaging, or brain fMRI are standard, and are providing relevant data routinely. Skin MR and hyperpolarized gas lung MRI are still experimental. In conclusion, considering the importance of finding and characterizing biomarkers for improved drug evaluation, it can be expected that the use of MR techniques in pharmaceutical research is going to increase in the near future. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:3637-3665, 2008.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available